Open Access

Transcriptomic analysis reveals Streptococcus agalactiae activation of oncogenic pathways in cervical adenocarcinoma

  • Authors:
    • Hong Duc Thi Nguyen
    • Tan Minh Le
    • Da-Ryung Jung
    • Youngjae Jo
    • Yeseul Choi
    • Donghyeon Lee
    • Olive Em Lee
    • Junghwan Cho
    • Nora Jee-Young Park
    • Incheol Seo
    • Gun Oh Chong
    • Jae-Ho Shin
    • Hyung Soo Han
  • View Affiliations

  • Published online on: October 3, 2024     https://doi.org/10.3892/ol.2024.14720
  • Article Number: 588
  • Copyright: © Nguyen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cervical adenocarcinoma (AC), a subtype of uterine cervical cancer (CC), poses a challenge due to its resistance to therapy and poor prognosis compared with squamous cervical carcinoma. Streptococcus agalactiae [group B Streptococcus (GBS)], a Gram‑positive coccus, has been associated with cervical intraepithelial neoplasia in CC. However, the underlying mechanism interaction between GBS and CC, particularly AC, remains elusive. Leveraging The Cancer Genome Atlas public data and time‑series transcriptomic data, the present study investigated the interaction between GBS and AC, revealing activation of two pivotal pathways: ‘MAPK signaling pathway’ and ‘mTORC1 signaling’. Western blotting, reverse transcription‑quantitative PCR and cell viability assays were performed to validate the activation of these pathways and their role in promoting cancer cell proliferation. Subsequently, the present study evaluated the efficacy of two anticancer drugs targeting these pathways (binimetinib and ridaforolimus) in AC cell treatment. Binimetinib demonstrated a cytostatic effect, while ridaforolimus had a modest impact on HeLa cells after 48 h of treatment, as observed in both cell viability and cytotoxicity assays. The combination of binimetinib and ridaforolimus resulted in a significantly greater cytotoxic effect compared to binimetinib or ridaforolimus monotherapy, although the synergy score indicated an additive effect. In general, the MAPK and mTORC1 signaling pathways were identified as the main pathways associated with GBS and AC cells. The combination of binimetinib and ridaforolimus could be a potential AC treatment.
View Figures
View References

Related Articles

Journal Cover

December-2024
Volume 28 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nguyen HT, Le TM, Jung D, Jo Y, Choi Y, Lee D, Lee O, Cho J, Park N, Seo I, Seo I, et al: Transcriptomic analysis reveals <em>Streptococcus agalactiae</em> activation of oncogenic pathways in cervical adenocarcinoma. Oncol Lett 28: 588, 2024.
APA
Nguyen, H.T., Le, T.M., Jung, D., Jo, Y., Choi, Y., Lee, D. ... Han, H. (2024). Transcriptomic analysis reveals <em>Streptococcus agalactiae</em> activation of oncogenic pathways in cervical adenocarcinoma. Oncology Letters, 28, 588. https://doi.org/10.3892/ol.2024.14720
MLA
Nguyen, H. T., Le, T. M., Jung, D., Jo, Y., Choi, Y., Lee, D., Lee, O., Cho, J., Park, N., Seo, I., Chong, G. O., Shin, J., Han, H."Transcriptomic analysis reveals <em>Streptococcus agalactiae</em> activation of oncogenic pathways in cervical adenocarcinoma". Oncology Letters 28.6 (2024): 588.
Chicago
Nguyen, H. T., Le, T. M., Jung, D., Jo, Y., Choi, Y., Lee, D., Lee, O., Cho, J., Park, N., Seo, I., Chong, G. O., Shin, J., Han, H."Transcriptomic analysis reveals <em>Streptococcus agalactiae</em> activation of oncogenic pathways in cervical adenocarcinoma". Oncology Letters 28, no. 6 (2024): 588. https://doi.org/10.3892/ol.2024.14720